ARCHIVES

Secondary AML In High-Dose Chemo Trial Cause For Careful Monitoring, NCI Says

This article is from The Cancer Letter archive.

Vol. 20 No. 33 | August 19, 1994

Download PDF Visit The Full Archive

Related Articles

Community Cancer Centers Selected For Pilot Program.

June 22, 2007

Funding Opportunities: RFA: Cancer Research Network Across Health Care Systems

September 12, 1997

More Cost-Effective To Use Cetuximab In Patients With Wild-Type KRAS Gene

August 28, 2009

Radium Society To Meet In L.A.

March 2, 1979

In Brief: Cancer Panel To Meet Aug.29; RFP On Impact Of Planning Cancelled As Being “Premature“

August 15, 1980

How NCI Plans To Spend Funds In FY 1980

July 14, 1978